Effects of Protein on Muscle, Gut Microbiota and Clinical Outcome in Patients With Lung Cancer-related Sarcopenia
Lung Cancer, Sarcopenia
About this trial
This is an interventional treatment trial for Lung Cancer focused on measuring soy protein, whey protein, lung cancer related sarcopenia
Eligibility Criteria
Inclusion Criteria: age>=18years old Patients with lung cancer and sarcopenia ECOG<=2 Patients are able to provide written informed consent. Exclusion Criteria: People who are allergic to soy protein and whey protein. Participants received any drugs or supplements known to influence effcet size, such as protein powder, anabolic steroids, or glucorticosteroid before the 3 months preceding the study. Participants with gastrointestinal bleeding, enterotomy or gastric bypass surgery before the 3 months preceding the study. Concurrent severe cardiac disease, liver and renal failure, which may significantly interfere with study compliance. Participants with electronic or mental device.
Sites / Locations
- Peking Union Medical College Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
soy protein intervention
whey protein intervention
control
This group received dietary guidance and soy protein intervention for 3 months
This group received dietary guidance and whey protein intervention for 3 months
This group received dietary guidance and mltodextrin for 3 months